Korea Exchange Signs Business Agreement with Korea Health Industry Development Institute

Purpose of Enhancing Analysis of Companies Applying for Review in the Bio and Medical Device Sector

The Korea Exchange announced on the 24th at 11 a.m. at its Seoul office that it signed a business agreement with the Korea Health Industry Development Institute to advance the analysis of companies applying for review in the bio and medical device sectors. From the left, Hong Sun-wook, Head of the KOSDAQ Market Division at the Korea Exchange, and Han Kwang-hyup, President of the Korea Health Industry Development Institute (Photo by Korea Exchange).

[Asia Economy Reporter Gong Byung-sun] The Korea Exchange announced on the 24th that it has signed a Memorandum of Understanding (MOU) for mutual cooperation with the National Evidence-based Healthcare Collaborating Agency (NECA).

The two organizations entered into this agreement to enhance the analysis of technological performance and business feasibility of companies applying for review in the bio and medical device sectors. It is expected to contribute to the sound development of the KOSDAQ market and investor protection in the future.

The main contents of this agreement include sharing medical technology and medical technology evaluation results related to specially designated technology companies, sharing medical technology evaluation methodologies and specialized healthcare knowledge, supporting related education, and providing scientific evidence and advisory services on healthcare technology.

Hong Soon-wook, Head of the KOSDAQ Market Division at the Korea Exchange, stated, “The expertise in reviewing technology companies will be further strengthened through verified information,” adding, “This will greatly contribute to the development of the KOSDAQ market.”